Hsu-Ping Kuo

发表

IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance.

M. Hung, C. chou, Yongkun Wei, 2008, International journal of molecular medicine.

TNFalpha induces HIF-1alpha expression through activation of IKKbeta.

M. Hung, W. Xia, Yongkun Wei, 2009, Biochemical and biophysical research communications.

TNF a induces HIF-1 a expression through activation of IKK b

M. Hung, W. Xia, Yongkun Wei, 2009 .

The suppression of MAD1 by AKT‐mediated phosphorylation activates MAD1 target genes transcription

M. Hung, J. Hsu, C. chou, 2009, Molecular carcinogenesis.

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

M. Hung, S. Tsai, I. Fidler, 2010, Science Signaling.

Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein?

M. Hung, Hsu-Ping Kuo, 2010, American journal of translational research.

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.

Douglas B. Evans, M. Hung, W. Xia, 2007, Cancer cell.

KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.

M. Hung, S. Tsai, Chia-Wei Li, 2009, Molecular cell.

TNF α induces HIF-1 α expression through activation of IKK β

Hung, W. Xia, Yongkun Wei, 2009 .

Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma

Chung-Pin Li, Y. Chao, Hsu-Ping Kuo, 2005, Journal of immunotherapy.

Ibrutinib Potentiated NK Cell-Mediated Cytotoxicity in Mouse Models of B-Cell Lymphomas

Hsu-Ping Kuo, B. Chang, M. Sirisawad, 2016 .

Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers.

M. Hung, Yueh-Fu Fang, W. Xia, 2013, Cancer cell.

Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.

M. Hung, J. Hsu, W. Xia, 2008, Cancer research.

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

G. Mills, G. Hortobagyi, C. Hsiao, 2008, Nature Cell Biology.

The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.

Z. Weng, M. Cleary, Hsu-Ping Kuo, 2015, Cancer cell.

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation

Chang-Hai Tsai, Chao-Kai Chou, M. Hung, 2011, Nature Cell Biology.

Epigenetic roles of MLL oncoproteins are dependent on NF-κB.

M. Figueroa, M. Cleary, Chiou-Hong Lin, 2013, Cancer cell.

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

Yung‐Chie Lee, King-Jen Chang, M. Hung, 2004, Cancer Gene Therapy.

The role of PIM 1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

Shiquan Wu, Hsu-Ping Kuo, Chun-Te Chen, 2016 .

IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

G. Hortobagyi, M. Hung, J. Hsu, 2007, Cell.

Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

G. Hortobagyi, M. Hung, J. Hsu, 2012, Molecular Cancer Therapeutics.

Preclinical Development Targeting the IKK b / mTOR / VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

G. Hortobagyi, M. Hung, J. Hsu, 2012 .

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.

L. Ellis, S. Curley, L. Jeng, 2011, The Journal of clinical investigation.

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.

Shiquan Wu, Hsu-Ping Kuo, Chun-Te Chen, 2015, American journal of cancer research.

Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Hsu-Ping Kuo, Chun-Te Chen, Scott A. Ezell, 2017, Molecular Cancer Therapeutics.

IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.

M. Karin, M. Hung, J. Hsu, 2012, Molecules and Cells.

Enhancement of Bik antitumor effect by Bik mutants.

M. Hung, Q. Ding, B. Zhou, 2003, Cancer research.

Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.

M. Hung, W. Xia, Dung-Fang Lee, 2009, Biochemical and biophysical research communications.

Combination of Ibrutinib and BCL-2 or SYK Inhibitors in Ibrutinib Resistant ABC-Subtype of Diffuse Large B-Cell Lymphoma

Hsu-Ping Kuo, M. Versele, L. Xue, 2014 .

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

Kenneth K Wang, J. Ajani, Tsung-Teh Wu, 2008, Cancer research.